American Oncology Network, Inc.
AONC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $69 | $39 | $419 | $406 |
| - Cash | $63 | $29 | $27 | $27 |
| + Debt | $147 | $128 | $127 | $64 |
| Enterprise Value | $154 | $139 | $519 | $443 |
| Revenue | $1,759 | $1,279 | $1,150 | $944 |
| % Growth | 37.5% | 11.3% | 21.8% | – |
| Gross Profit | $118 | $83 | $95 | $78 |
| % Margin | 6.7% | 6.5% | 8.3% | 8.3% |
| EBITDA | $2 | -$39 | $23 | $8 |
| % Margin | 0.1% | -3.1% | 2% | 0.8% |
| Net Income | -$4 | -$6 | $3 | -$0 |
| % Margin | -0.2% | -0.4% | 0.2% | -0% |
| EPS Diluted | -0.69 | -1.36 | 0.062 | -0.003 |
| % Growth | 49.3% | -2,290% | 2,584% | – |
| Operating Cash Flow | -$5 | -$18 | -$7 | -$26 |
| Capital Expenditures | -$21 | -$12 | -$7 | -$8 |
| Free Cash Flow | -$26 | -$30 | -$14 | -$35 |